Literature DB >> 26944031

Detection and Quantification of Mosaic Mutations in Disease Genes by Next-Generation Sequencing.

Lan Qin1, Jing Wang2, Xia Tian1, Hui Yu1, Cavatina Truong1, John J Mitchell3, Klaas J Wierenga4, William J Craigen5, Victor Wei Zhang2, Lee-Jun C Wong6.   

Abstract

The identification of mosaicism is important in establishing a disease diagnosis, assessing recurrence risk, and genetic counseling. Next-generation sequencing (NGS) with deep sequence coverage enhances sensitivity and allows for accurate quantification of the level of mosaicism. NGS identifies low-level mosaicism that would be undetectable by conventional Sanger sequencing. A customized DNA probe library was used for capturing targeted genes, followed by deep NGS analysis. The mean coverage depth per base was approximately 800×. The NGS sequence data were analyzed for single-nucleotide variants and copy number variations. Mosaic mutations in 10 cases/families were detected and confirmed by NGS analysis. Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders. The mosaicism was identified either in one or more tissues from the probands or in a parent of an affected child. When analyzing data from patients with unusual testing results or inheritance patterns, it is important to further evaluate the possibility of mosaicism. Deep NGS analysis not only provides insights into the spectrum of mosaic mutations but also underlines the importance of the detection of mosaicism as an integral part of clinical molecular diagnosis and genetic counseling.
Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26944031     DOI: 10.1016/j.jmoldx.2016.01.002

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  26 in total

1.  Somatic mosaicism for a lethal TRPV4 mutation results in non-lethal metatropic dysplasia.

Authors:  Michael M Weinstein; Taekyu Kang; Ralph S Lachman; Michael Bamshad; Deborah A Nickerson; Deborah Krakow; Daniel H Cohn
Journal:  Am J Med Genet A       Date:  2016-08-17       Impact factor: 2.802

2.  A Novel Synonymous Variant of PHEX in a Patient with X-Linked Hypophosphatemia.

Authors:  Xiaosen Ma; Qianqian Pang; Qi Zhang; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Weibo Xia
Journal:  Calcif Tissue Int       Date:  2022-07-14       Impact factor: 4.000

3.  Identification of a novel TBX5 c.755 + 1 G > A variant and related pathogenesis in a family with Holt-Oram syndrome.

Authors:  De-Gang Wang; Xing-Sheng Dong; Yi Xiong; Zhi-Ming Li; Ying-Jun Xie; Shu-Hua Liang; Tian-Hua Huang
Journal:  Am J Med Genet A       Date:  2021-09-06       Impact factor: 2.578

4.  Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Catherine Rehder; Lora J H Bean; David Bick; Elizabeth Chao; Wendy Chung; Soma Das; Julianne O'Daniel; Heidi Rehm; Vandana Shashi; Lisa M Vincent
Journal:  Genet Med       Date:  2021-04-29       Impact factor: 8.822

5.  Non-Penetrance for Ocular Phenotype in Two Individuals Carrying Heterozygous Loss-of-Function ZEB1 Alleles.

Authors:  Lubica Dudakova; Viktor Stranecky; Lenka Piherova; Tomas Palecek; Nikolas Pontikos; Stanislav Kmoch; Pavlina Skalicka; Manuela Vaneckova; Alice E Davidson; Petra Liskova
Journal:  Genes (Basel)       Date:  2021-04-30       Impact factor: 4.096

6.  Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia.

Authors:  Andrea G Maria; Mari Suzuki; Annabel Berthon; Crystal Kamilaris; Andrew Demidowich; Justin Lack; Mihail Zilbermint; Fady Hannah-Shmouni; Fabio R Faucz; Constantine A Stratakis
Journal:  Am J Hypertens       Date:  2020-02-22       Impact factor: 3.080

7.  Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.

Authors:  Elizabeth Harris; Ana Topf; Rita Barresi; Judith Hudson; Helen Powell; James Tellez; Debbie Hicks; Anna Porter; Marta Bertoli; Teresinha Evangelista; Chiara Marini-Betollo; Ólafur Magnússon; Monkol Lek; Daniel MacArthur; Kate Bushby; Hanns Lochmüller; Volker Straub
Journal:  Orphanet J Rare Dis       Date:  2017-09-06       Impact factor: 4.123

8.  Next-generation sequencing corroborates a probable de novo GNPTG variation previously detected by Sanger sequencing.

Authors:  Nataniel Floriano Ludwig; Fernanda Sperb-Ludwig; Renata Voltolini Velho; Ida Vanessa D Schwartz
Journal:  Mol Genet Metab Rep       Date:  2017-03-01

9.  Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan.

Authors:  Wen-Chen Liang; Xia Tian; Chung-Yee Yuo; Wan-Zi Chen; Tsu-Min Kan; Yi-Ning Su; Ichizo Nishino; Lee-Jun C Wong; Yuh-Jyh Jong
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

10.  Case Report: Identification of Maternal Low-Level Mosaicism in the Dystrophin Gene by Droplet Digital Polymerase Chain Reaction.

Authors:  Pengzhen Jin; Xiaoyang Gao; Miaomiao Wang; Yeqing Qian; Jingjin Yang; Yanmei Yang; Yuqing Xu; Yanfei Xu; Minyue Dong
Journal:  Front Genet       Date:  2021-07-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.